We're here to help you with your drug development challenges
Ask the Experts
Talk to our scientific panel
Whether your question is associated with optimizing your formulation or manufacturing process or planning your clinical pharmacology study, we are here to help.
Our experts have insight into a variety of topics, including:
- Minimizing chemistry costs and moving drug substance supply off the critical path
- Transitioning between drug substance and drug product manufacturing
- Selecting the best formulation technology for poorly soluble molecules
- Meeting clinical trial program needs while reducing cost and waste
- Ensuring maximum flexibility in clinical manufacturing and batch sizes
- Using real-time clinical data to make better formulation decisions
Learn more about our experience and ask our team a question today.
Meet our Experts
More from our team
-
Thought LeadershipAndy Lewis speaks about modified-release dosage forms in Drug Development & DeliveryAndy Lewis, Vice President, Pharmaceutical Sciences, has written an article for Drug Development & Delivery entitled, "Alternative Strategies for Development of Modified-Release Dosage Forms"
-
Thought LeadershipHelen Baker Featured in Drug Development & Delivery ArticleHelen Baker, Director of Pharmaceutical Sciences, has been featured in Drug Development & Delivery's special feature article, "Outsourcing Formulation Development & Manufacturing: Understanding Critical Attributes Earlier in Development Leads to a More Robust Drug Product."
-
Thought LeadershipDCAT Value Chain Insights - CDMO Roundtable: Managing Orphan Drug ProjectsRoundtable Interview with Paul Quigley, Principal Research Fellow, Drug Substance,& John McDermott, Executive Drug Development Consultant. Low-volume drugs, such as orphan drugs, present challenges in achieving favorable production economics and in managing the projects themselves. A roundtable of CDMOs provides perspectives on those challenges and best practices to resolve them.
-
Thought LeadershipMark Egerton, CEO of Quotient Sciences - 'Keeping Up With Demands: CDMOs diversify their capabilities to meet their clients’ complex requirements', featured in Global Business ReportsMark Egerton, CEO of Quotient Sciences, has been featured in and article in Global Business Reports: "Keeping Up With Demands: CDMOs diversify their capabilities to meet their clients’ complex requirements."
Get in touch
Humanity can’t afford to wait, so neither can we.
Let’s talk.